Gene · 8846
Papers2,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL1-mediated m7G tRNA modification promotes colorectal cancer progression and liver metastasis via translational regulation. | Cell Oncol (Dordr) | 2026 | 41627602 | PubTator, text mining | PubMed |
| Characterization of the Citrus Leaf Blotch Virus AlkB Domain and Its Involvement in Viral Accumulation. | Phytopathology | 2026 | 41621092 | PubTator, text mining | PubMed |
| Context-specific Angiogenin-mediated tRNA fragments (tDRs) biogenesis shapes the mitochondrial stress response. | Redox Biol | 2026 | 41604938 | PubTator, text mining | PubMed |
| ALKBH1 gene polymorphisms confer hepatoblastoma susceptibility in Chinese children. | Sci Rep | 2026 | 41565983 | PubTator, text mining | PubMed |
| BMSC-derived extracellular vesicles affect gluconeogenesis and lipogenesis by releasing 5'-tRF-GlyCCC to improve MAFLD insulin sensitivity. | Cell Biol Toxicol | 2026 | 41530468 | PubTator, text mining | PubMed |
| Unveiling the landscape of m5C RNA methylation in lung cancer: From molecular mechanisms to therapeutic opportunities. | Biochem Biophys Res Commun | 2026 | 41519051 | PubTator, text mining | PubMed |
| Revolutionizing microbial treasure troves: innovative strategies for natural products discovery. | Nat Prod Bioprospect | 2026 | 41518510 | PubTator, text mining | PubMed |
| Association of ALKBH1 overexpression with metastasis, prognosis, and immunotherapy response in head and neck squamous cell carcinoma. | Odontology | 2026 | 41483323 | PubTator, text mining | PubMed |
| Dysregulation of ERAD and Stress Response Proteins by V493F FTO Over-expression: A Proteomic Perspective. | In Vivo | 2026 | 41482413 | PubTator, text mining | PubMed |
| Post-transcriptional modifications on tRNA fragments confer functional changes to high-density lipoproteins in atherosclerosis. | Atherosclerosis | 2026 | 41380623 | PubTator, text mining | PubMed |
| Structure-based Discovery of a Non-competitive FTO Inhibitor Bound to a Cryptic Site at the Domain Interface. | J Mol Biol | 2026 | 41354147 | PubTator, text mining | PubMed |
| Phylogenomics provides insights into the phylogeny of Liliales and the evolution of colchicine biosynthesis genes. | Mol Phylogenet Evol | 2026 | 41338406 | PubTator, text mining | PubMed |
| TWAS atlas 2.0: an updated data resource for transcriptome-wide association studies. | Nucleic Acids Res | 2026 | 41251136 | PubTator, text mining | PubMed |
| Integration of epigenetics into ecotoxicology: insights and fundamental research needs. | Biol Rev Camb Philos Soc | 2026 | 41242758 | PubTator, text mining | PubMed |
| Binding and Translocation of Substrate Allosterically Promotes Functional Interactions Within the AlkB-AlkG Electron Transfer Complex. | J Mol Biol | 2026 | 41242542 | PubTator, text mining | PubMed |
| Bacterial community diversity associated with oil degradation from marine environment. | Mar Pollut Bull | 2026 | 41166777 | PubTator, text mining | PubMed |
| Perinatal clinical management of a rare ABh variant blood group. | Transfus Med | 2026 | 41126780 | PubTator, text mining | PubMed |
| CD133-Guided RNA Nanoparticle Delivery of FTO siRNA Impairs Leukemia Resistance to Tyrosine Kinase Inhibitor Therapy. | RNA Nanomed | 2025 | 42004278 | PubTator, text mining | PubMed |
| Targeted RNA base editing for therapeutic: mechanisms and advances. | Pharm Sci Adv | 2025 | 41550651 | PubTator, text mining | PubMed |
| Molecular dynamic analysis of the functional role of amino acid residues V99, F124 and S125 of human DNA dioxygenase ABH2. | Vavilovskii Zhurnal Genet Selektsii | 2025 | 41536795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8846/papers?page=3